Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Attention Deficit Disorder with Hyperactivity | 243 | 2024 | 3649 | 17.290 |
Why?
|
Central Nervous System Stimulants | 92 | 2024 | 1148 | 13.290 |
Why?
|
Substance-Related Disorders | 109 | 2024 | 4250 | 10.360 |
Why?
|
Methylphenidate | 38 | 2021 | 473 | 5.030 |
Why?
|
Propylamines | 27 | 2012 | 165 | 3.490 |
Why?
|
Adrenergic Uptake Inhibitors | 20 | 2014 | 189 | 2.710 |
Why?
|
Conduct Disorder | 16 | 2023 | 241 | 2.590 |
Why?
|
Opioid-Related Disorders | 21 | 2024 | 2062 | 2.110 |
Why?
|
Bipolar Disorder | 46 | 2023 | 5024 | 1.910 |
Why?
|
Methamphetamine | 3 | 2024 | 152 | 1.820 |
Why?
|
Adolescent | 213 | 2024 | 85649 | 1.700 |
Why?
|
Psychotropic Drugs | 14 | 2015 | 893 | 1.690 |
Why?
|
Guanfacine | 7 | 2020 | 51 | 1.670 |
Why?
|
Comorbidity | 83 | 2024 | 10372 | 1.640 |
Why?
|
Executive Function | 7 | 2024 | 1362 | 1.560 |
Why?
|
Antidepressive Agents, Tricyclic | 21 | 2006 | 434 | 1.530 |
Why?
|
Alcoholism | 15 | 2021 | 1904 | 1.370 |
Why?
|
Delayed-Action Preparations | 25 | 2021 | 965 | 1.320 |
Why?
|
Amphetamines | 11 | 2008 | 148 | 1.320 |
Why?
|
Child | 198 | 2024 | 77478 | 1.280 |
Why?
|
Students | 8 | 2023 | 1647 | 1.280 |
Why?
|
Smoking | 19 | 2016 | 8969 | 1.120 |
Why?
|
Mental Disorders | 35 | 2022 | 6587 | 1.120 |
Why?
|
Desipramine | 16 | 2005 | 184 | 1.120 |
Why?
|
Adolescent Psychiatry | 3 | 2024 | 148 | 1.080 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2016 | 87 | 1.040 |
Why?
|
Opiate Substitution Treatment | 7 | 2023 | 404 | 0.990 |
Why?
|
Bupropion | 11 | 2006 | 303 | 0.970 |
Why?
|
Pyrrolidines | 4 | 2010 | 342 | 0.970 |
Why?
|
Psychiatric Status Rating Scales | 52 | 2015 | 6030 | 0.970 |
Why?
|
Humans | 347 | 2024 | 742088 | 0.950 |
Why?
|
Amphetamine-Related Disorders | 1 | 2024 | 67 | 0.930 |
Why?
|
Self Medication | 5 | 2015 | 117 | 0.920 |
Why?
|
Cocaine | 3 | 2024 | 1008 | 0.910 |
Why?
|
Child Psychiatry | 5 | 2024 | 220 | 0.870 |
Why?
|
Antidepressive Agents | 19 | 2014 | 2838 | 0.830 |
Why?
|
Prescription Drugs | 4 | 2020 | 595 | 0.800 |
Why?
|
Tic Disorders | 8 | 2024 | 127 | 0.770 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 9 | 2023 | 304 | 0.770 |
Why?
|
Female | 225 | 2024 | 379592 | 0.770 |
Why?
|
Parents | 12 | 2021 | 3387 | 0.750 |
Why?
|
Antidepressive Agents, Second-Generation | 6 | 2005 | 503 | 0.740 |
Why?
|
Analgesics, Opioid | 14 | 2023 | 3667 | 0.740 |
Why?
|
Male | 214 | 2024 | 349538 | 0.740 |
Why?
|
Tourette Syndrome | 11 | 2017 | 379 | 0.730 |
Why?
|
Mood Disorders | 10 | 2019 | 1106 | 0.730 |
Why?
|
Heart Rate | 13 | 2022 | 4091 | 0.730 |
Why?
|
Alcohol-Induced Disorders | 3 | 2011 | 26 | 0.720 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2021 | 168 | 0.720 |
Why?
|
Substance Abuse, Intravenous | 3 | 2019 | 522 | 0.700 |
Why?
|
Indans | 3 | 2006 | 96 | 0.690 |
Why?
|
Clonidine | 11 | 2006 | 164 | 0.690 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2019 | 27 | 0.670 |
Why?
|
Buprenorphine | 7 | 2023 | 640 | 0.670 |
Why?
|
Child of Impaired Parents | 6 | 2018 | 455 | 0.670 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2024 | 633 | 0.660 |
Why?
|
Double-Blind Method | 35 | 2021 | 12017 | 0.660 |
Why?
|
Methadone | 8 | 2023 | 306 | 0.660 |
Why?
|
Adult | 130 | 2024 | 213712 | 0.650 |
Why?
|
Family Health | 10 | 2014 | 1282 | 0.650 |
Why?
|
Postpartum Period | 3 | 2023 | 1078 | 0.640 |
Why?
|
Phenobarbital | 1 | 2019 | 192 | 0.640 |
Why?
|
Dopamine Uptake Inhibitors | 2 | 2015 | 312 | 0.640 |
Why?
|
Young Adult | 38 | 2024 | 56350 | 0.630 |
Why?
|
Drug Administration Schedule | 24 | 2017 | 4929 | 0.630 |
Why?
|
Dose-Response Relationship, Drug | 26 | 2017 | 10943 | 0.610 |
Why?
|
Child Behavior | 3 | 2019 | 838 | 0.600 |
Why?
|
Adolescent Behavior | 9 | 2019 | 1150 | 0.600 |
Why?
|
Marijuana Smoking | 2 | 2017 | 252 | 0.600 |
Why?
|
Adrenergic alpha-Agonists | 4 | 2011 | 177 | 0.590 |
Why?
|
Nicotinic Agonists | 4 | 2010 | 271 | 0.590 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 16 | 2016 | 1953 | 0.590 |
Why?
|
Social Problems | 3 | 2022 | 112 | 0.580 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 175 | 0.580 |
Why?
|
Outpatients | 3 | 2023 | 1483 | 0.580 |
Why?
|
Benzodiazepines | 4 | 2023 | 1101 | 0.570 |
Why?
|
Social Environment | 2 | 2020 | 1023 | 0.550 |
Why?
|
Blood Pressure | 12 | 2022 | 8541 | 0.540 |
Why?
|
Mothers | 5 | 2023 | 2163 | 0.540 |
Why?
|
Psychopharmacology | 2 | 2014 | 143 | 0.540 |
Why?
|
Family | 14 | 2019 | 3144 | 0.530 |
Why?
|
Autistic Disorder | 2 | 2021 | 1174 | 0.530 |
Why?
|
Patient Dropouts | 2 | 2017 | 421 | 0.520 |
Why?
|
Cannabinoids | 1 | 2017 | 166 | 0.510 |
Why?
|
Treatment Outcome | 57 | 2022 | 62966 | 0.510 |
Why?
|
Psychopathology | 5 | 2024 | 402 | 0.500 |
Why?
|
Anxiety Disorders | 17 | 2022 | 2684 | 0.500 |
Why?
|
Nortriptyline | 7 | 2000 | 81 | 0.500 |
Why?
|
Drug Therapy, Combination | 14 | 2016 | 6483 | 0.500 |
Why?
|
Hypnotics and Sedatives | 3 | 2019 | 1158 | 0.490 |
Why?
|
Risk Factors | 57 | 2022 | 72145 | 0.490 |
Why?
|
Prevalence | 25 | 2019 | 15194 | 0.480 |
Why?
|
Marijuana Abuse | 4 | 2022 | 402 | 0.480 |
Why?
|
Placebos | 13 | 2011 | 1677 | 0.480 |
Why?
|
Child Behavior Disorders | 10 | 2002 | 807 | 0.470 |
Why?
|
Depressive Disorder | 18 | 2007 | 3748 | 0.460 |
Why?
|
Dextroamphetamine | 3 | 2012 | 129 | 0.460 |
Why?
|
Pregnancy Complications | 4 | 2021 | 2861 | 0.460 |
Why?
|
Naltrexone | 4 | 2023 | 307 | 0.460 |
Why?
|
Schools | 6 | 2023 | 1425 | 0.450 |
Why?
|
Age Factors | 36 | 2020 | 18355 | 0.450 |
Why?
|
Diagnosis, Dual (Psychiatry) | 9 | 2014 | 295 | 0.440 |
Why?
|
Case-Control Studies | 27 | 2020 | 21719 | 0.440 |
Why?
|
Cross-Over Studies | 13 | 2015 | 2030 | 0.440 |
Why?
|
Isoxazoles | 2 | 2007 | 216 | 0.430 |
Why?
|
Nootropic Agents | 2 | 2020 | 160 | 0.420 |
Why?
|
Pyridines | 3 | 2010 | 2818 | 0.410 |
Why?
|
Sertraline | 2 | 2006 | 206 | 0.410 |
Why?
|
Tobacco Use Disorder | 2 | 2008 | 685 | 0.410 |
Why?
|
Neuropsychological Tests | 19 | 2018 | 6974 | 0.410 |
Why?
|
Piperidines | 3 | 2006 | 1602 | 0.400 |
Why?
|
Cholinesterase Inhibitors | 2 | 2006 | 239 | 0.400 |
Why?
|
Antipsychotic Agents | 8 | 2020 | 3058 | 0.400 |
Why?
|
Age of Onset | 12 | 2023 | 3266 | 0.400 |
Why?
|
Antimanic Agents | 5 | 2009 | 522 | 0.390 |
Why?
|
Massachusetts | 14 | 2024 | 8662 | 0.390 |
Why?
|
Personality Assessment | 13 | 2012 | 643 | 0.380 |
Why?
|
Aggression | 5 | 2023 | 753 | 0.380 |
Why?
|
Perioperative Care | 1 | 2018 | 997 | 0.380 |
Why?
|
Alcohol-Related Disorders | 4 | 2019 | 234 | 0.380 |
Why?
|
Cognition | 10 | 2023 | 6722 | 0.380 |
Why?
|
Universities | 5 | 2020 | 953 | 0.370 |
Why?
|
Cholinergic Agents | 4 | 2004 | 93 | 0.360 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12344 | 0.360 |
Why?
|
Psychotherapy | 7 | 2022 | 1644 | 0.360 |
Why?
|
Amphetamine | 4 | 2019 | 225 | 0.350 |
Why?
|
Pemoline | 4 | 2005 | 18 | 0.350 |
Why?
|
Obsessive-Compulsive Disorder | 5 | 2003 | 1442 | 0.350 |
Why?
|
Medication Adherence | 1 | 2021 | 2055 | 0.350 |
Why?
|
Central Nervous System Depressants | 2 | 2011 | 167 | 0.340 |
Why?
|
Fluoxetine | 3 | 2002 | 749 | 0.340 |
Why?
|
Motivation | 7 | 2020 | 1968 | 0.340 |
Why?
|
Student Dropouts | 2 | 2018 | 27 | 0.330 |
Why?
|
Delivery of Health Care | 4 | 2024 | 5304 | 0.330 |
Why?
|
Tachycardia | 3 | 2005 | 620 | 0.320 |
Why?
|
Prescriptions | 5 | 2024 | 387 | 0.320 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2017 | 1341 | 0.310 |
Why?
|
Depressive Disorder, Major | 5 | 2022 | 4628 | 0.300 |
Why?
|
Norepinephrine | 2 | 2008 | 909 | 0.300 |
Why?
|
Attention | 6 | 2013 | 2396 | 0.290 |
Why?
|
Administration, Cutaneous | 4 | 2015 | 711 | 0.290 |
Why?
|
Siblings | 5 | 2016 | 854 | 0.280 |
Why?
|
United States Food and Drug Administration | 1 | 2014 | 1581 | 0.280 |
Why?
|
Cannabis | 2 | 2023 | 432 | 0.280 |
Why?
|
United States | 25 | 2024 | 69693 | 0.270 |
Why?
|
Hostility | 1 | 2006 | 189 | 0.270 |
Why?
|
Exercise Test | 2 | 2012 | 2075 | 0.270 |
Why?
|
Psychometrics | 5 | 2020 | 2999 | 0.260 |
Why?
|
Antihypertensive Agents | 5 | 2006 | 2043 | 0.260 |
Why?
|
Hypertension | 4 | 2012 | 8455 | 0.250 |
Why?
|
Synaptic Transmission | 2 | 2008 | 1179 | 0.250 |
Why?
|
Follow-Up Studies | 29 | 2018 | 39004 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3014 | 0.250 |
Why?
|
Death, Sudden, Cardiac | 3 | 2006 | 1541 | 0.250 |
Why?
|
Dietary Supplements | 1 | 2017 | 3294 | 0.250 |
Why?
|
Antisocial Personality Disorder | 5 | 2023 | 227 | 0.240 |
Why?
|
Self Report | 4 | 2022 | 3548 | 0.240 |
Why?
|
Retrospective Studies | 31 | 2024 | 77098 | 0.240 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 2023 | 109 | 0.240 |
Why?
|
Inpatients | 3 | 2024 | 2495 | 0.240 |
Why?
|
Personality Development | 2 | 1995 | 245 | 0.240 |
Why?
|
Clomipramine | 2 | 1995 | 54 | 0.230 |
Why?
|
Ambulatory Care | 8 | 2021 | 2706 | 0.230 |
Why?
|
Ethanol | 2 | 2011 | 1337 | 0.230 |
Why?
|
Electrocardiography | 9 | 2009 | 6440 | 0.230 |
Why?
|
Interview, Psychological | 6 | 2016 | 812 | 0.230 |
Why?
|
Dopamine | 3 | 2008 | 1589 | 0.220 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2002 | 33 | 0.220 |
Why?
|
Referral and Consultation | 6 | 2002 | 3527 | 0.220 |
Why?
|
Pregnancy | 15 | 2023 | 29087 | 0.220 |
Why?
|
Residential Treatment | 1 | 2024 | 111 | 0.220 |
Why?
|
Valproic Acid | 4 | 2009 | 446 | 0.220 |
Why?
|
Middle Aged | 42 | 2023 | 213127 | 0.220 |
Why?
|
Drug Prescriptions | 4 | 2023 | 1636 | 0.220 |
Why?
|
Longitudinal Studies | 16 | 2022 | 13921 | 0.210 |
Why?
|
Sex Factors | 15 | 2016 | 10392 | 0.210 |
Why?
|
Pilot Projects | 7 | 2017 | 8297 | 0.200 |
Why?
|
Nicotine | 1 | 2007 | 677 | 0.200 |
Why?
|
Narcotic Antagonists | 1 | 2006 | 562 | 0.200 |
Why?
|
Reference Values | 3 | 2019 | 4982 | 0.200 |
Why?
|
Social Work | 1 | 2023 | 162 | 0.200 |
Why?
|
Tranquilizing Agents | 2 | 2018 | 59 | 0.200 |
Why?
|
Checklist | 2 | 2020 | 830 | 0.200 |
Why?
|
Alcohol Drinking | 2 | 2011 | 3957 | 0.200 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2006 | 615 | 0.200 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2008 | 422 | 0.200 |
Why?
|
Cognition Disorders | 8 | 2011 | 4030 | 0.190 |
Why?
|
Sex Distribution | 5 | 2008 | 2295 | 0.190 |
Why?
|
Emotions | 1 | 2013 | 2657 | 0.190 |
Why?
|
Clinical Trials as Topic | 7 | 2014 | 7901 | 0.190 |
Why?
|
Psychiatry | 2 | 2024 | 1695 | 0.190 |
Why?
|
Affective Symptoms | 2 | 2011 | 407 | 0.190 |
Why?
|
Risk-Taking | 1 | 2006 | 986 | 0.180 |
Why?
|
Time Factors | 11 | 2019 | 40054 | 0.180 |
Why?
|
Cocaine-Related Disorders | 1 | 2024 | 460 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6534 | 0.180 |
Why?
|
Cannabidiol | 1 | 2021 | 106 | 0.180 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 24913 | 0.170 |
Why?
|
Substance Abuse Detection | 3 | 2007 | 283 | 0.170 |
Why?
|
Nausea | 3 | 2017 | 665 | 0.170 |
Why?
|
Educational Status | 2 | 2018 | 2533 | 0.170 |
Why?
|
Severity of Illness Index | 17 | 2015 | 15530 | 0.170 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2005 | 585 | 0.170 |
Why?
|
Poison Control Centers | 1 | 2019 | 72 | 0.170 |
Why?
|
Child, Preschool | 28 | 2023 | 40955 | 0.170 |
Why?
|
Focus Groups | 1 | 2024 | 1320 | 0.170 |
Why?
|
Enuresis | 1 | 1998 | 47 | 0.170 |
Why?
|
Mass Screening | 6 | 2021 | 5238 | 0.160 |
Why?
|
Heart | 1 | 2012 | 4462 | 0.160 |
Why?
|
Prospective Studies | 20 | 2022 | 53187 | 0.160 |
Why?
|
Parenting | 2 | 2023 | 676 | 0.150 |
Why?
|
Protriptyline | 1 | 1996 | 7 | 0.150 |
Why?
|
Social Class | 6 | 2016 | 1995 | 0.150 |
Why?
|
Anti-Anxiety Agents | 1 | 1999 | 390 | 0.150 |
Why?
|
Drug Tolerance | 1 | 2018 | 375 | 0.140 |
Why?
|
Analysis of Variance | 4 | 2016 | 6365 | 0.140 |
Why?
|
Depression | 3 | 2018 | 7733 | 0.140 |
Why?
|
Diagnosis, Differential | 11 | 2014 | 12958 | 0.140 |
Why?
|
Drug Interactions | 7 | 2003 | 1458 | 0.140 |
Why?
|
Maternal Exposure | 1 | 2023 | 961 | 0.140 |
Why?
|
Drug Monitoring | 3 | 2010 | 956 | 0.140 |
Why?
|
Administration, Oral | 4 | 2010 | 3913 | 0.130 |
Why?
|
Dwarfism | 1 | 1996 | 145 | 0.130 |
Why?
|
Statistics as Topic | 4 | 2016 | 2372 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2019 | 1780 | 0.130 |
Why?
|
Qualitative Research | 1 | 2024 | 2680 | 0.130 |
Why?
|
Transdermal Patch | 1 | 2015 | 51 | 0.130 |
Why?
|
Cyclohexanols | 1 | 1995 | 127 | 0.130 |
Why?
|
Confidence Intervals | 3 | 2008 | 2970 | 0.130 |
Why?
|
Intention | 1 | 2017 | 338 | 0.120 |
Why?
|
Drug Therapy | 1 | 2017 | 497 | 0.120 |
Why?
|
Vomiting | 1 | 2017 | 632 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2017 | 9941 | 0.120 |
Why?
|
Databases as Topic | 2 | 2006 | 475 | 0.120 |
Why?
|
Child Abuse | 1 | 2023 | 1030 | 0.120 |
Why?
|
Health Surveys | 5 | 2020 | 4030 | 0.120 |
Why?
|
Heroin Dependence | 1 | 2014 | 175 | 0.120 |
Why?
|
Central Nervous System Agents | 1 | 2014 | 72 | 0.110 |
Why?
|
Growth Disorders | 1 | 1998 | 643 | 0.110 |
Why?
|
Demography | 3 | 2008 | 1650 | 0.110 |
Why?
|
Histamine Agonists | 1 | 2012 | 11 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1123 | 0.110 |
Why?
|
Psychotic Disorders | 3 | 2011 | 3040 | 0.110 |
Why?
|
Logistic Models | 8 | 2023 | 13403 | 0.110 |
Why?
|
Developmental Disabilities | 2 | 2010 | 1452 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7276 | 0.110 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 950 | 0.110 |
Why?
|
Peer Group | 1 | 2017 | 635 | 0.100 |
Why?
|
Carbamazepine | 2 | 2006 | 229 | 0.100 |
Why?
|
Social Behavior | 3 | 2006 | 1128 | 0.100 |
Why?
|
Incidence | 8 | 2020 | 20928 | 0.100 |
Why?
|
Tricuspid Valve | 1 | 2014 | 400 | 0.100 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1246 | 0.100 |
Why?
|
Infant | 7 | 2023 | 35070 | 0.100 |
Why?
|
Triazoles | 1 | 1997 | 907 | 0.100 |
Why?
|
Liver Function Tests | 2 | 2009 | 528 | 0.100 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2023 | 2407 | 0.100 |
Why?
|
School Health Services | 1 | 2015 | 375 | 0.100 |
Why?
|
Odds Ratio | 5 | 2020 | 9846 | 0.100 |
Why?
|
Long-Term Care | 3 | 2005 | 607 | 0.100 |
Why?
|
Remedial Teaching | 1 | 2010 | 13 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1218 | 0.100 |
Why?
|
Achievement | 5 | 2009 | 291 | 0.100 |
Why?
|
Anxiety | 4 | 2021 | 4279 | 0.100 |
Why?
|
Risk | 3 | 2016 | 9679 | 0.090 |
Why?
|
Quinazolinones | 1 | 2012 | 221 | 0.090 |
Why?
|
Endocarditis, Bacterial | 1 | 2014 | 453 | 0.090 |
Why?
|
Thioridazine | 1 | 1990 | 33 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2011 | 3510 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2414 | 0.090 |
Why?
|
Communication | 2 | 2019 | 3728 | 0.090 |
Why?
|
Body Height | 1 | 1996 | 1574 | 0.090 |
Why?
|
Obstetric Labor Complications | 1 | 2012 | 238 | 0.090 |
Why?
|
Metabolic Clearance Rate | 4 | 2012 | 379 | 0.090 |
Why?
|
Hemodynamics | 2 | 2001 | 4197 | 0.090 |
Why?
|
Parent-Child Relations | 2 | 2008 | 747 | 0.090 |
Why?
|
Trichotillomania | 1 | 1992 | 172 | 0.090 |
Why?
|
Osmotic Pressure | 1 | 2010 | 151 | 0.090 |
Why?
|
Corticosterone | 4 | 1985 | 310 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2023 | 25575 | 0.090 |
Why?
|
Independent Living | 1 | 2013 | 564 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 10 | 2016 | 17400 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2005 | 8621 | 0.080 |
Why?
|
Intelligence Tests | 2 | 2007 | 505 | 0.080 |
Why?
|
Cardiovascular System | 2 | 2006 | 827 | 0.080 |
Why?
|
Placebo Effect | 2 | 2009 | 502 | 0.080 |
Why?
|
Panic Disorder | 2 | 2009 | 616 | 0.080 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2008 | 64 | 0.080 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2008 | 31 | 0.080 |
Why?
|
Patient Care Team | 3 | 2008 | 2527 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7141 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1436 | 0.080 |
Why?
|
Safety | 2 | 2006 | 1185 | 0.080 |
Why?
|
Dexamethasone | 3 | 1985 | 1949 | 0.080 |
Why?
|
Methionine Sulfoximine | 2 | 1984 | 12 | 0.080 |
Why?
|
Hydrocortisone | 3 | 1985 | 1825 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 322 | 0.070 |
Why?
|
Intelligence | 3 | 2011 | 920 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 245 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2716 | 0.070 |
Why?
|
Wechsler Scales | 3 | 2008 | 260 | 0.070 |
Why?
|
Mianserin | 1 | 2006 | 52 | 0.070 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2004 | 158 | 0.070 |
Why?
|
Psychological Tests | 4 | 2011 | 648 | 0.070 |
Why?
|
Self Administration | 1 | 2008 | 386 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1067 | 0.070 |
Why?
|
Receptors, Dopamine D1 | 1 | 2008 | 291 | 0.070 |
Why?
|
Epilepsy | 2 | 2017 | 3301 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 1574 | 0.070 |
Why?
|
Osmosis | 1 | 2006 | 113 | 0.070 |
Why?
|
Primary Health Care | 2 | 2021 | 4551 | 0.070 |
Why?
|
Receptors, Dopamine D2 | 1 | 2008 | 475 | 0.070 |
Why?
|
Sleep Initiation and Maintenance Disorders | 3 | 2017 | 997 | 0.070 |
Why?
|
Memory, Short-Term | 3 | 2008 | 972 | 0.070 |
Why?
|
Nicotinic Antagonists | 1 | 2006 | 96 | 0.070 |
Why?
|
Body Weight | 1 | 1996 | 4664 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 15108 | 0.070 |
Why?
|
Patient Discharge | 1 | 2018 | 3300 | 0.070 |
Why?
|
Length of Stay | 1 | 2019 | 6294 | 0.070 |
Why?
|
Tachycardia, Supraventricular | 1 | 2008 | 263 | 0.070 |
Why?
|
Self-Help Groups | 1 | 2006 | 187 | 0.060 |
Why?
|
Mother-Child Relations | 1 | 2009 | 481 | 0.060 |
Why?
|
Affect | 2 | 2003 | 1473 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6532 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 604 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
Narcotics | 1 | 2007 | 343 | 0.060 |
Why?
|
Psychophysiologic Disorders | 1 | 2006 | 228 | 0.060 |
Why?
|
Receptors, Nicotinic | 1 | 2007 | 497 | 0.060 |
Why?
|
Cohort Studies | 5 | 2022 | 40450 | 0.060 |
Why?
|
Sex Characteristics | 2 | 2005 | 2585 | 0.060 |
Why?
|
Drug Evaluation | 1 | 2005 | 637 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 1 | 2010 | 1157 | 0.060 |
Why?
|
Pirenzepine | 1 | 2003 | 115 | 0.060 |
Why?
|
Temperament | 1 | 2005 | 283 | 0.060 |
Why?
|
Case Management | 1 | 2005 | 286 | 0.060 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1423 | 0.060 |
Why?
|
S-Adenosylhomocysteine | 5 | 1984 | 42 | 0.060 |
Why?
|
Interviews as Topic | 3 | 2006 | 2536 | 0.060 |
Why?
|
Quantitative Trait, Heritable | 1 | 2006 | 544 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2003 | 424 | 0.050 |
Why?
|
Social Adjustment | 5 | 2011 | 630 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 632 | 0.050 |
Why?
|
Homocysteine | 5 | 1984 | 647 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 418 | 0.050 |
Why?
|
Psychology | 1 | 2024 | 355 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2011 | 4328 | 0.050 |
Why?
|
Puberty | 1 | 2005 | 489 | 0.050 |
Why?
|
Pain | 1 | 2017 | 4961 | 0.050 |
Why?
|
Peripartum Period | 1 | 2023 | 133 | 0.050 |
Why?
|
Corpus Striatum | 1 | 2008 | 1220 | 0.050 |
Why?
|
Dizziness | 2 | 2006 | 250 | 0.050 |
Why?
|
Pharmacogenetics | 1 | 2006 | 676 | 0.050 |
Why?
|
Reproducibility of Results | 6 | 2015 | 19862 | 0.050 |
Why?
|
Drug Synergism | 1 | 2005 | 1791 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2009 | 4248 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 7770 | 0.050 |
Why?
|
Models, Psychological | 1 | 2005 | 810 | 0.050 |
Why?
|
Brain | 9 | 2010 | 26343 | 0.050 |
Why?
|
Risk Assessment | 4 | 2019 | 23320 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2003 | 592 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10232 | 0.050 |
Why?
|
Receptors, Presynaptic | 1 | 2000 | 15 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 2885 | 0.050 |
Why?
|
Causality | 1 | 2007 | 1265 | 0.050 |
Why?
|
Age Distribution | 2 | 2004 | 2900 | 0.050 |
Why?
|
Receptors, Catecholamine | 1 | 2000 | 6 | 0.050 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2005 | 469 | 0.050 |
Why?
|
Area Under Curve | 2 | 2003 | 1653 | 0.050 |
Why?
|
Automobile Driving | 1 | 2005 | 431 | 0.040 |
Why?
|
Cholinergic Agonists | 1 | 1999 | 74 | 0.040 |
Why?
|
Anger | 1 | 2022 | 402 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 1990 | 2267 | 0.040 |
Why?
|
Prefrontal Cortex | 2 | 2008 | 2146 | 0.040 |
Why?
|
Aged | 7 | 2023 | 162944 | 0.040 |
Why?
|
Regression Analysis | 4 | 2003 | 6452 | 0.040 |
Why?
|
Appetite | 2 | 2017 | 243 | 0.040 |
Why?
|
Echocardiography | 1 | 2012 | 5097 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2051 | 0.040 |
Why?
|
New York City | 1 | 2021 | 706 | 0.040 |
Why?
|
Smoking Cessation | 2 | 2008 | 2068 | 0.040 |
Why?
|
Phenotype | 4 | 2008 | 16331 | 0.040 |
Why?
|
Receptors, Dopamine | 1 | 1999 | 294 | 0.040 |
Why?
|
Anticonvulsants | 2 | 2006 | 1914 | 0.040 |
Why?
|
Tandem Repeat Sequences | 1 | 1999 | 185 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 471 | 0.040 |
Why?
|
Forecasting | 2 | 2005 | 2948 | 0.040 |
Why?
|
Continuity of Patient Care | 1 | 2005 | 1048 | 0.040 |
Why?
|
Disulfiram | 1 | 1998 | 57 | 0.040 |
Why?
|
Genetic Testing | 1 | 2011 | 3439 | 0.040 |
Why?
|
Patient Compliance | 2 | 2005 | 2680 | 0.040 |
Why?
|
Risperidone | 1 | 1999 | 383 | 0.040 |
Why?
|
Genome-Wide Association Study | 3 | 2011 | 12220 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2022 | 866 | 0.040 |
Why?
|
Attitude | 1 | 2022 | 772 | 0.040 |
Why?
|
Sympatholytics | 1 | 1996 | 83 | 0.040 |
Why?
|
Medical Records | 3 | 1999 | 1413 | 0.040 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2016 | 108 | 0.040 |
Why?
|
Psychological Techniques | 1 | 2016 | 45 | 0.040 |
Why?
|
Prognosis | 5 | 2008 | 29010 | 0.040 |
Why?
|
Growth | 1 | 1998 | 376 | 0.030 |
Why?
|
Drug Users | 1 | 2018 | 131 | 0.030 |
Why?
|
Self-Assessment | 1 | 1998 | 390 | 0.030 |
Why?
|
Nerve Net | 1 | 2008 | 2174 | 0.030 |
Why?
|
Live Birth | 1 | 2019 | 512 | 0.030 |
Why?
|
Clinical Protocols | 2 | 1998 | 1459 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2018 | 275 | 0.030 |
Why?
|
Environment | 1 | 2002 | 1115 | 0.030 |
Why?
|
Lithium | 1 | 1998 | 601 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1998 | 545 | 0.030 |
Why?
|
Hospitals, General | 1 | 2019 | 749 | 0.030 |
Why?
|
Child Welfare | 1 | 1999 | 523 | 0.030 |
Why?
|
Verbal Learning | 2 | 2008 | 466 | 0.030 |
Why?
|
Probability | 2 | 1997 | 2502 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1995 | 284 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2020 | 819 | 0.030 |
Why?
|
Nerve Tissue Proteins | 3 | 1984 | 4465 | 0.030 |
Why?
|
Pediatrics | 1 | 2009 | 3462 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 736 | 0.030 |
Why?
|
Research Design | 3 | 2009 | 5979 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 824 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1694 | 0.030 |
Why?
|
Nuclear Family | 2 | 2009 | 318 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2005 | 1895 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1407 | 0.030 |
Why?
|
Internal-External Control | 1 | 1995 | 363 | 0.030 |
Why?
|
Fear | 1 | 2022 | 1436 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 364 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3528 | 0.030 |
Why?
|
Colic | 1 | 2012 | 42 | 0.030 |
Why?
|
Language | 1 | 2022 | 1458 | 0.030 |
Why?
|
Adenosine | 5 | 1984 | 823 | 0.030 |
Why?
|
Linear Models | 4 | 2011 | 5948 | 0.030 |
Why?
|
Caregivers | 1 | 2023 | 2074 | 0.030 |
Why?
|
Thyroid Diseases | 1 | 1995 | 378 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3611 | 0.030 |
Why?
|
Semaphorin-3A | 1 | 2011 | 39 | 0.030 |
Why?
|
Biological Availability | 1 | 2012 | 396 | 0.030 |
Why?
|
Psychology, Social | 1 | 2011 | 51 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15056 | 0.020 |
Why?
|
Epidemics | 1 | 2017 | 521 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 999 | 0.020 |
Why?
|
Cardiac Complexes, Premature | 1 | 1990 | 64 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 2011 | 318 | 0.020 |
Why?
|
Neurologic Examination | 1 | 1993 | 931 | 0.020 |
Why?
|
S-Adenosylmethionine | 4 | 1984 | 212 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3937 | 0.020 |
Why?
|
Sensory Gating | 1 | 2008 | 47 | 0.020 |
Why?
|
Child Development | 1 | 2000 | 2222 | 0.020 |
Why?
|
Family Relations | 1 | 2011 | 321 | 0.020 |
Why?
|
Liver | 2 | 2003 | 7470 | 0.020 |
Why?
|
Vital Signs | 1 | 2009 | 141 | 0.020 |
Why?
|
Ammonia | 1 | 2009 | 239 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1129 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2007 | 1895 | 0.020 |
Why?
|
Heart Block | 1 | 1990 | 410 | 0.020 |
Why?
|
Pre-Excitation Syndromes | 1 | 2008 | 27 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9305 | 0.020 |
Why?
|
Methylation | 4 | 1984 | 1107 | 0.020 |
Why?
|
Self Disclosure | 1 | 2009 | 251 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2005 | 5133 | 0.020 |
Why?
|
Hospitals, University | 1 | 2009 | 571 | 0.020 |
Why?
|
Heart Ventricles | 2 | 1990 | 3801 | 0.020 |
Why?
|
Chest Pain | 1 | 2014 | 1113 | 0.020 |
Why?
|
Histamine | 3 | 1984 | 507 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 392 | 0.020 |
Why?
|
California | 1 | 2011 | 1400 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 822 | 0.020 |
Why?
|
Cause of Death | 1 | 1997 | 3571 | 0.020 |
Why?
|
Fever | 1 | 2014 | 1612 | 0.020 |
Why?
|
Genotype | 3 | 2010 | 12946 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1298 | 0.020 |
Why?
|
Systole | 1 | 2009 | 956 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2009 | 1676 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 791 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 508 | 0.020 |
Why?
|
Piperazines | 1 | 1997 | 2488 | 0.020 |
Why?
|
Problem Solving | 1 | 2008 | 440 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 1985 | 918 | 0.020 |
Why?
|
Hematocrit | 1 | 2007 | 636 | 0.020 |
Why?
|
Anorexia | 1 | 2006 | 159 | 0.020 |
Why?
|
Disease Progression | 4 | 2005 | 13256 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 1990 | 453 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 440 | 0.020 |
Why?
|
Blood Cells | 1 | 2007 | 309 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2010 | 35342 | 0.020 |
Why?
|
Diplopia | 1 | 2006 | 199 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23387 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2007 | 975 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2010 | 15494 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1661 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7716 | 0.020 |
Why?
|
Methylhistamines | 1 | 1984 | 4 | 0.020 |
Why?
|
Hepatitis C | 1 | 2014 | 1582 | 0.020 |
Why?
|
Reaction Time | 2 | 2008 | 2092 | 0.020 |
Why?
|
Methionine | 2 | 1984 | 590 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8626 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1659 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 7010 | 0.010 |
Why?
|
Adenosine Deaminase Inhibitors | 1 | 1982 | 9 | 0.010 |
Why?
|
Nucleoside Deaminases | 1 | 1982 | 58 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1983 | 379 | 0.010 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2003 | 106 | 0.010 |
Why?
|
Movement Disorders | 1 | 2006 | 444 | 0.010 |
Why?
|
Dysthymic Disorder | 1 | 2002 | 74 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2005 | 1003 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2370 | 0.010 |
Why?
|
Biogenic Amines | 1 | 1981 | 50 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2005 | 1589 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 1985 | 553 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3215 | 0.010 |
Why?
|
Polyamines | 1 | 1981 | 120 | 0.010 |
Why?
|
Tics | 1 | 2001 | 70 | 0.010 |
Why?
|
Cross Reactions | 1 | 1983 | 841 | 0.010 |
Why?
|
Phospholipids | 2 | 1983 | 781 | 0.010 |
Why?
|
Neurons | 1 | 2000 | 9325 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2699 | 0.010 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1985 | 703 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1503 | 0.010 |
Why?
|
Genetic Variation | 2 | 2010 | 6540 | 0.010 |
Why?
|
Animals | 7 | 2007 | 168561 | 0.010 |
Why?
|
Remission, Spontaneous | 1 | 2000 | 380 | 0.010 |
Why?
|
Diseases in Twins | 1 | 2002 | 450 | 0.010 |
Why?
|
Benzhydryl Compounds | 1 | 2006 | 840 | 0.010 |
Why?
|
Seizures | 2 | 1983 | 2851 | 0.010 |
Why?
|
Dopamine Agents | 1 | 2000 | 189 | 0.010 |
Why?
|
Physician's Role | 1 | 2006 | 942 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1981 | 547 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1219 | 0.010 |
Why?
|
Epinephrine | 1 | 1981 | 793 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12242 | 0.010 |
Why?
|
Recurrence | 2 | 1999 | 8333 | 0.010 |
Why?
|
Meta-Analysis as Topic | 1 | 2002 | 1342 | 0.010 |
Why?
|
Pancreatitis | 1 | 2003 | 1090 | 0.010 |
Why?
|
Lung | 1 | 2014 | 9826 | 0.010 |
Why?
|
Brain Stem | 1 | 1981 | 844 | 0.010 |
Why?
|
Thyroid Hormone Resistance Syndrome | 1 | 1995 | 16 | 0.010 |
Why?
|
Multigene Family | 1 | 1999 | 1102 | 0.010 |
Why?
|
Memory | 1 | 2005 | 2163 | 0.010 |
Why?
|
Weight Loss | 1 | 2006 | 2604 | 0.010 |
Why?
|
Education, Special | 1 | 1995 | 87 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2008 | 2746 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7873 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 1995 | 0.010 |
Why?
|
Marital Status | 1 | 1995 | 437 | 0.010 |
Why?
|
Triiodothyronine | 1 | 1995 | 494 | 0.010 |
Why?
|
Genetic Markers | 1 | 1999 | 2633 | 0.010 |
Why?
|
Adenosylhomocysteinase | 2 | 1982 | 3 | 0.010 |
Why?
|
Thyrotropin | 1 | 1995 | 850 | 0.010 |
Why?
|
Thyroxine | 1 | 1995 | 666 | 0.010 |
Why?
|
Syndrome | 1 | 1998 | 3248 | 0.010 |
Why?
|
Hydrolases | 2 | 1982 | 139 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2003 | 2400 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1982 | 4664 | 0.010 |
Why?
|
Alleles | 1 | 1999 | 6931 | 0.000 |
Why?
|
Sleep | 1 | 2001 | 4604 | 0.000 |
Why?
|
Survival Analysis | 1 | 1998 | 10248 | 0.000 |
Why?
|
Data Collection | 1 | 1995 | 3339 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1996 | 2575 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1982 | 10163 | 0.000 |
Why?
|
Quality of Life | 1 | 2005 | 12730 | 0.000 |
Why?
|
Mice | 4 | 1984 | 81045 | 0.000 |
Why?
|
Deoxyadenosines | 1 | 1982 | 27 | 0.000 |
Why?
|
Peromyscus | 1 | 1981 | 17 | 0.000 |
Why?
|
Putrescine | 1 | 1981 | 40 | 0.000 |
Why?
|
Spermidine | 1 | 1981 | 56 | 0.000 |
Why?
|
Histamine N-Methyltransferase | 1 | 1981 | 2 | 0.000 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 1981 | 18 | 0.000 |
Why?
|
Spermine | 1 | 1981 | 70 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1983 | 1827 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14720 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1983 | 981 | 0.000 |
Why?
|
Acoustic Stimulation | 1 | 1981 | 1216 | 0.000 |
Why?
|
Adenine | 1 | 1982 | 936 | 0.000 |
Why?
|
Cell Division | 1 | 1982 | 4564 | 0.000 |
Why?
|
Circadian Rhythm | 1 | 1981 | 2623 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1982 | 19223 | 0.000 |
Why?
|
Rats | 1 | 1981 | 24265 | 0.000 |
Why?
|